| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.09 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |